We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+4.85%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$355M
AUM Growth
-$57.3M
Cap. Flow
-$68.9M
Cap. Flow %
-19.43%
Top 10 Hldgs %
63.26%
Holding
33
New
3
Increased
9
Reduced
16
Closed
5

Top Buys

Rank Stock Value
1
UHS icon
Universal Health Services
UHS
+$11.5M
2
CVS icon
CVS Health
CVS
+$6.8M
3
BMY icon
Bristol-Myers Squibb
BMY
+$6.31M
4
VTRS icon
Viatris
VTRS
+$5.03M
5
AGIO icon
Agios Pharmaceuticals
AGIO
+$4.4M

Top Sells

Rank Stock Value
1
CNC icon
Centene
CNC
+$15M
2
LH icon
Labcorp
LH
+$11.5M
3
THC icon
Tenet Healthcare
THC
+$10.4M
4
GEHC icon
GE HealthCare
GEHC
+$10.4M
5
BIIB icon
Biogen
BIIB
+$9.96M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDT icon
1
Medtronic
MDT
$106B
$35.9M 10.12%
411,893
-23,182
-5% -$1.98M
PFE icon
2
Pfizer
PFE
$143B
$34.4M 9.69%
1,239,165
+145,749
+13% +$4.04M
BMY icon
3
Bristol-Myers Squibb
BMY
$124B
$27M 7.62%
498,536
+123,849
+33% +$6.31M
CVS icon
4
CVS Health
CVS
$137B
$24.6M 6.92%
308,004
+89,004
+41% +$6.8M
CAH icon
5
Cardinal Health
CAH
$53.5B
$20.4M 5.76%
182,587
+18,282
+11% +$1.97M
GILD icon
6
Gilead Sciences
GILD
$167B
$19.5M 5.48%
265,619
-116,743
-31% -$8.98M
ELV icon
7
Elevance Health
ELV
$80.9B
$17.8M 5.01%
34,297
+6,490
+23% +$3.23M
ZBH icon
8
Zimmer Biomet
ZBH
$17.6B
$16M 4.5%
121,033
-20,185
-14% -$2.52M
INCY icon
9
Incyte
INCY
$23.4B
$15.1M 4.25%
264,895
-133,804
-34% -$8.03M
BAX icon
10
Baxter International
BAX
$11.7B
$13.8M 3.89%
323,120
-5,012
-2% -$204K
BIIB icon
11
Biogen
BIIB
$30.4B
$12.9M 3.63%
59,698
-42,536
-42% -$9.96M
UHS icon
12
Universal Health Services
UHS
$9.15B
$12.8M 3.59%
+69,881
New +$11.5M
BIO icon
13
Bio-Rad Laboratories Class A
BIO
$8.15B
$11.6M 3.28%
33,662
+10,053
+43% +$3.31M
GEHC icon
14
GE HealthCare
GEHC
$28.7B
$11.2M 3.16%
123,133
-124,398
-50% -$10.4M
BRKR icon
15
Bruker
BRKR
$8.86B
$10.6M 2.99%
112,775
-14,537
-11% -$1.17M
EW icon
16
Edwards Lifesciences
EW
$49.4B
$10.2M 2.88%
106,866
-80,690
-43% -$6.78M
THC icon
17
Tenet Healthcare
THC
$16.8B
$8.15M 2.3%
77,535
-115,744
-60% -$10.4M
IONS icon
18
Ionis Pharmaceuticals
IONS
$8.99B
$7.61M 2.14%
175,507
+30,495
+21% +$1.45M
BMRN icon
19
BioMarin Pharmaceuticals
BMRN
$11.5B
$7.11M 2%
81,416
-4,831
-6% -$432K
ALKS icon
20
Alkermes
ALKS
$8.79B
$6.83M 1.93%
252,319
+52,319
+26% +$1.49M
GMED icon
21
Globus Medical
GMED
$10.5B
$5.65M 1.59%
105,381
-128,993
-55% -$6.93M
VTRS icon
22
Viatris
VTRS
$20.1B
$4.99M 1.41%
+417,657
New +$5.03M
AGIO icon
23
Agios Pharmaceuticals
AGIO
$2.36B
$4.81M 1.35%
+164,378
New +$4.4M
QGEN icon
24
Qiagen
QGEN
$8.49B
$4.44M 1.25%
100,498
-79,191
-44% -$3.61M
ALNY icon
25
Alnylam Pharmaceuticals
ALNY
$35.7B
$4.12M 1.16%
27,583
-4,509
-14% -$752K
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q1 2024 Portfolio in Review

As of Q1 2024, Sector Gamma AS held 33 positions worth $355M, down 14% from $412M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Sector Gamma AS withdrew a net $68.9M in Q1 2024, closing 5 positions and reducing 16 holdings. Its most notable exit was Labcorp, an estimated $11.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Sector Gamma AS opened a new position in Universal Health Services worth $12.8M.

  • Sector Gamma AS's largest Q1 2024 buy was Universal Health Services: 69,881 shares worth $12.8M.
  • Sector Gamma AS added most to CVS Health in Q1 2024, an estimated $6.8M increase.
  • Sector Gamma AS's biggest Q1 2024 reduction was Centene, cutting an estimated $15M.
  • Sector Gamma AS fully exited Labcorp in Q1 2024, selling an estimated $11.5M.
  • Sector Gamma AS's ten largest holdings make up 63% of its $355M portfolio in Q1 2024.
  • Sector Gamma AS opened 3 new positions and closed 5 in Q1 2024.
  • Sector Gamma AS's portfolio value fell 14% quarter-over-quarter to $355M.

Based on Sector Gamma AS's 13F filing for Q1 2024, filed 8 May 2024.